Two sets of collaborative experiments between ISCO and exhaust systems have been found that corneal tissue corneal tissue ISCO topical drug absorption displays barrier properties and tissue – appropriate enzymatic activity, making a promising a promising model for studying human ocular drug absorption as an alternative to live animal testing. Further experimentsthe human cornea is created in the laboratories of its wholly owned subsidiary, Lifeline Cell Technology .
The collaboration between Absorption Systems and ISCO uses Absorption Systems ‘ expertise in the preparation and characterization of test systems to develop superior preclinical methods of testing drugs Such methods may include the use of laboratory animals currently necessary for other tests, including. Safety testing of consumer products.. Van der Linden M, Reinert R. Impacts of national immunization program on PCV7 at IPD for children in Germany. Poster presented at 26th Annual Meeting of the European Society Pediatric Infectious Diseases introduced.